The existing knowledge in the field shows that medical cannabis can ease the side effects of chemotherapy and relieve cancer patients’ pain more effectively than conventional treatments. New research also points to a more substantial potential in curing the disease.
Many studies that were embraced by the global medical community, as well as institutions such as the DEA and the FDA in the US, prove that smoking or inhaling cannabis can significantly reduce side effects such as nausea, vomiting, lack of appetite and pain. Research proved that medical cannabis treatment is more efficient compared to conventional treatments when it comes to treating nausea and vomiting and can also decrease the need for pharmaceutical painkillers.
Based on this and other data, many cancer patients who are going through chemotherapy and suffer from side effects and pain receive medical cannabis permits and treatment.
It’s important to keep in mind that medical cannabis isn’t considered a medication and every professional in the field is extremely careful in pointing out that it should be relied on solely for treating cancer. Nevertheless, new studies point to a possible change in that aspect in the future. Nearly all of the research around the topic of medical cannabis as a supporting or main cure for cancer are in their initial stages and are being presented by medical professionals as no more than a potential concept, but there’s room to believe that recent revelations will speed up research in the field and lead to the development of cannabis-based cancer medication.
Several studies state that medical cannabis treatment may have the ability to slow down the development of cancerous cells in certain types of cancer, this contributing to the impact of other oncological treatments.
The alternative media website CE has gathered information based on 20 different studies that point to the potential of medical cannabis in curing cancer. These studies examine a wide range of cancer types, including brain cancer, breast cancer, lung cancer, prostate cancer, leukemia, mouth cancer, liver cancer and pancreas cancer.
Research conducted at the Technion, the Israel Institute of Technology tested the influence of 50 medical cannabis variations on the development of cancerous cells in 200 different types of the disease. The results demonstrate the potential abilities of medical cannabis in slowing down the disease as well as killing the cancerous cells in a process called Apoptosis.
These results were published in May 2015 and have brought great optimism to both patients and professionals regarding the possibility of developing a medical cannabis-based cure for cancer. This is a promising and exciting potential which could mark a new era in the field.